Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Medical Climbs on Robust Earnings

publication date: Jun 19, 2007
Solid Profits from Medical Devices -- China Medical Technologies (CMED) has enjoyed a very positive two-day run after announcing its fiscal year 2006 revenues and earnings. The stock moved up $4.39 to $31.64 over the first two sessions of the week, a 16% climb. The company reported that its revenues shot up 47.1% to $71 million and profits were 46% higher at $38 million. Both numbers beat analysts predictions as well as the company's own forecast. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital